The relationship between oxidant-antioxidant status and bronchial obstructive parameters in patients with COPD
Автор: Solongo Kh., Gombosuren B., Narantsetseg J., Ambaga M.
Журнал: Вестник Бурятского государственного университета. Философия @vestnik-bsu
Статья в выпуске: 12, 2015 года.
Бесплатный доступ
Air pollution has major health impacts on people living in Ulaanbaatar. As written in the WORLD BANK report: ”Ambient annual average particulate matter concentrations in the capital of Mongolia are 10-25 times greater than Mongolian air quality standards and are among the highest recorded measurements in any world capital. ”Chronic obstructive pulmonary disease (COPD) induced by air pollution wasfound to be a major cause of illness in Mongolia. We measured a wide range of parameters of the oxidant-antioxidant status in erythrocyte membrane, cytosol, plasma and urine of 188 patients with COPD and 48 healthy controls (HC). All data used in this paper is gathered since 2008 at the First National Central Hospital of Mongolia. Using the data mining methodology we selected highly effective features among them. Correlations between features were determined by SPSS 20. Also the results were analyzed using SPSS 20 for Windows; data are reported as mean, standard deviations and standard errors. The statistical significance was given by a p value
Chronic obstructive pulmonary disease, free radical scavenging activity, cytochrome c oxidase, lipid peroxides products, malondialdehyde
Короткий адрес: https://sciup.org/148182724
IDR: 148182724
Список литературы The relationship between oxidant-antioxidant status and bronchial obstructive parameters in patients with COPD
- Air quality analysis of Ulaanbaatar: the World Bank Report. 2011. Available at: http://ubairpollution.org/Papers/WorldBank2011_UB_report.pdf
- Dekhuijzen P.N., Aben K.K., Dekker I., Aarts L.P., Wielders P.L., Van Herwaarden C.L., Bast A. Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care MED. 1996. No. 154. No. 813-816.
- Del Rio D., Stewart A.J., Pellegrini N. A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr. Metab. Cardiovasc. Dis. No. 15. 2005. Pp. 316-328.
- Drost E.M., Skwarski K.M., Sauleda J., Soler N., Roca J., Agusti A., Macnee W. Oxidative stress and airway inflammation in severe exacerbations of COPD. Thorax. 2005. No. 60. Pp. 293-300.
- Duthie G.G., Arthur J.R., James W.P. Effects of smoking and vitamin E on blood antioxidant status. Am. J Clin. Nutr. 1991. No. 53. Pp. 1061-1063.
- Chan-Yeung M.A., Buncio D.Y. Leukocyte counts, smoking and lung function. Am. J. MED. 1984. No. 76. Pp. 31-37.
- Kinnula V.L., Crapo J.D. Superoxide dismutases in the lung and human lung diseases. Am. J. Respir. Crit. Care MED. 2003. No.167. Pp. 1600-1619.
- Kostikas K., Papatheodorou G., Psathakis K., Panagou P., Loukides S. Oxidative stress in expired breath condensate of patients with COPD. Chest. No. 24. 2003. Pp. 1373-1380.
- Linden M., Rasmussen J.B. Piitulainen E., Tunek A., Larson M., Tegner H., Venge P., Laitinen L.A., Brattsand R. Airway inflammation in smokers with non-obstructive and obstructive chronic bronchitis. Am. Rev. Respir. Dis. 1993. No. 148. Pp. 1226-1232.
- Global Initiative for Chronic Obstructive Lung Diseases (GOLD). Global strategy for diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO workshop report. 2009. Available at: www. goldcopd.org.
- Sasikala M., Subramanyam C., and Sadasivudu B. Early oxidative change in low density lipoproteins during progressive chronic renal failure. IND. J. Clin. Biochem. 1999. No. 14(2). Pp. 176-183.
- Yang M., Chen P., Peng H., Shen Q., Chen Y. Cytochrome C oxidase expression and endothelial cell apoptosis in the lungs of patients with chronic obstructive pulmonary disease. Zhonghua Jie He He Hu Xi Za Zhi. 2010. 33 (9). Pp. 665-669. Sep.
- MacNee W. Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 2005. No. 2. Pp. 50-60.
- Pauwels R.A., Buist A.S., Calverley P.M.A. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global initiative for chronic obstructive lung disease (GOLD) workshop summary. Am. J. Respir. Crit. Care MED. 2001. No. 163. Pp. 1256-1276.
- Paredi P., Kharitonov S.A., Leak D., Ward S., Cramer D., Barnes P.J. Exhaled ethane, a marker of lipid peroxidation, is elevated in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care MED. 2000. No. 62. Pp. 369-373.
- Schunemann H.J., Muti P., Freudenheim J.L., Armstrong D., Browne R., Klocke R.A., Trevisan M. Oxidative stress and lung function. Am. J. Epidemiol. 1997. No. 146. Pp. 939-948.
- Petruzzelli S., Hietanen E., Bartsch H., Camus A.M., Mussi A., Angeletti C.A., Saraccii R., Giuntini C. Pulmonary lipid peroxidation in cigarette smokers and lung cancer patients. Chest. 1990. No. 98. Pp. 930-935.
- Pratico D., Basili S., Vieri M., Cordova C., Violi F., Fitzgerald G.A. Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2a-III, an index of oxidant stress. Am. J. Respir. Crit. Care MED. No. 158. No. 1709-1714, 1998.
- Rahman I., Swarska E., Henry M., Stolk J., MacNee W. Is there any relationship between plasma antioxidant capacity and lung function in smokers and in patients with chronic obstructive pulmonary disease? Thorax. 2000. No. 55. No. 189-193.
- Repine J.E., Bast A., Lankhorst I., and the Oxidative Stress Study Group. Oxidative stress in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care MED. 1997. No. 156. Pp. 341-357.
- Tsukagoshi H., Shimizu Y., Iwamae S., Hisada T., Ishizuka K., Dobashi K., Mori M. Evidence of oxidative stress in asthma and COPD: potential inhibitory effect of theophylline. Respir. MED. 2000. No. 94. Pp. 584-588.
